Ermeg 0.2mg Injection
Marketer
Alembic Pharmaceuticals Ltd
Salt Composition
Methylergometrine (0.2mg)
Overview Ermeg 0.2mg Injection
Uterine bleeding following childbirth or termination of pregnancy may be managed with Ermeg 0.2mg Injection. This medication enhances uterine muscle tone, contraction frequency, and intensity, thereby minimizing postpartum hemorrhage. Administered intravenously or intramuscularly by a physician in a hospital setting only, self-injection is strictly prohibited. Dosage and frequency are determined by your doctor based on your individual needs and condition. Treatment duration is adjusted to optimize symptom relief. Headache, elevated blood pressure, and seizures are potential, though infrequent, adverse effects. Report any concerning symptoms to your doctor immediately; management strategies may be available. Alcohol consumption should be avoided during treatment. Prior to commencing therapy, inform your physician of any pre-existing heart conditions or hypertension, and provide a complete list of all other medications you are currently using, as potential drug interactions may impact Ermeg's efficacy or mechanism of action.
Uses of Ermeg 0.2mg Injection
Hemorrhage postpartum
Major Benefits of Ermeg 0.2mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Ermeg 0.2mg Injection:
- High blood pressure
- Headache
- Seizure
How to use Ermeg 0.2mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Ermeg 0.2mg Injection works:
Ergot alkaloid injection, Ermeg 0.2mg, induces prolonged uterine smooth muscle contractions. This vascular compression effectively manages postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ermeg 0.2mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Ermeg 0.2mg Injection during pregnancy carries a substantial risk. Pregnant individuals should consult their physician; research in animal and human subjects reveals considerable adverse consequences for fetal development.
Breast feedingCAUTION
Administering Ermeg 0.2mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the maternal system.
DrivingCONSULT YOUR DOCTOR
Ermeg 0.2mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ermeg 0.2mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ermeg 0.2mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Ermeg 0.2mg Injection :
NA
Facts to Know About Ermeg 0.2mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Ergoline Alkaloids |
| Developing Habits | No. |
| Treatment Category | OBSTETRICS AND GYNECOLOGY |
| Behavioral Class | Drugs inducing uterine contractions and/or abortion |
3,018 People bought this recently